MTLS - Materialise N.V.
Materialise (NASDAQ: MTLS) reported second-quarter revenue growth of more than 8% year over year to €70.1 million, driven by double-digit expansion in its Medical segment and continued improvement in profitability. The company raised its full-year adjusted EBIT outlook while maintaining its revenue guidance, despite the anticipated revenue effect of divesting its RapidFit and Eyewear businesses. Chief
Materialise NV (MTLS) Q2 2026 Earnings Call Transcript
Materialise NASDAQ: MTLS reported second-quarter revenue growth of more than 8% year over year to €70.1 million, driven by double-digit expansion in its Medical segment and continued improvement in profitability. The company raised its full-year adjusted EBIT outlook while maintaining its revenue guidance, despite the anticipated revenue effect of divesting its RapidFit and Eyewear businesses.
LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (Euronext & NASDAQ:MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, today announced its financial results for the second quarter and the six months ended June 30, 2026. Highlights – Second Quarter 2026 Total revenue increased by 8.1% to 70,073 kEUR for the second quarter of 2026 compared to 64,831 kEUR for the corresponding 2025 period. Adjusted EBITDA increased.
LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (Euronext & NASDAQ: MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, today announced that it will release financial results for the second quarter and the six months ended June 30, 2026 on Thursday, August 27, 2026 at 1:00 a.m. ET/7:00 a.m. CET. Senior management will hold a conference call to discuss the second quarter and the six months ended June 30, 2026 fina.
LEUVEN, Belgium, July 01, 2026 (GLOBE NEWSWIRE) -- MATERIALISE NV Technologielaan 153001 LeuvenCompany number: 0441.131.254RPR Leuven
LEUVEN, Belgium, June 17, 2026 (GLOBE NEWSWIRE) -- Regulated information [1]
Materialise (MTLS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
MTLS, LXFR and ARKO emerged as June breakout stock picks after strong gains and screening tied to price momentum and resistance levels.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Materialise NASDAQ: MTLS reported first-quarter 2026 revenue of EUR 66.3 million, which Chief Financial Officer Koen Berges said was stable year-over-year despite “significant foreign exchange headwinds,” primarily tied to a weaker U.S. dollar. Gross profit rose to EUR 37.9 million and gross margin expanded to 57.2%, helping drive improved profitability and positive free cash flow during the period.
Materialise NV (MTLS) Q1 2026 Earnings Call Transcript
LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (Euronext & NASDAQ:MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, today announced its financial results for the first quarter ended March 31, 2026. Additionally, Materialise announced the transfer of its eyewear business to the eyewear management team. Highlights – First Quarter 2026 Total revenue was stable at 66,276 kEUR for the first quarter of 2026 compared.
Materialise receives a 'Buy' rating, driven by robust growth in its medical segment despite weakness in software and manufacturing. MTLS's medical segment boasts a 4-year CAGR of 16%, with management guiding for continued strong growth through FY2026. The company maintains a fortress balance sheet with €71m net cash and trades at a significant discount to sector peers on EV/Sales and EV/EBITDA.
LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (Euronext & NASDAQ: MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, today announced that it will release financial results for the first quarter ended March 31, 2026 on Thursday, May 7, 2026 at 1:00 a.m. ET/7:00 a.m. CET. Senior management will hold a conference call to discuss the first quarter 2026 financial results on Thursday, May 7, 2026 at 8:30 a.m. ET/2:3.
Leuven (BELGIUM), March 31, 2026 (GLOBE NEWSWIRE) -- Materialise NV (Euronext & Nasdaq: MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, announces the decision to transfer its RapidFit business to its management team. Following the transaction, RapidFit will continue as an independent company under the ownership and leadership of the same team under the RapidFit name.
Materialise NV (NASDAQ: MTLS - Get Free Report)'s stock price crossed below its fifty day moving average during trading on Tuesday. The stock has a fifty day moving average of $5.52 and traded as low as $5.18. Materialise shares last traded at $5.21, with a volume of 60,331 shares. Wall Street Analyst Weigh In MTLS
Materialise is poised for a return to consistent growth and improving margins, led by Medical strength and stabilization of its Software business. The Manufacturing segment faces ongoing headwinds, but expansion into aerospace and defense could create a modest rebound over the next few years. The combination of a low valuation, consistent growth, and higher margins should lead the stock higher, which will be supported by a share buyback program.
Materialise NV (MTLS) Q4 2025 Earnings Call Transcript
LEUVEN, Belgium--(BUSINESS WIRE)---- $MTLS--Materialise NV (Euronext & NASDAQ:MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, today announced its financial results for the fourth quarter and full year ended December 31, 2025. Highlights – Fourth Quarter 2025 Total revenue increased by 6.8% to 70,164 kEUR for the fourth quarter of 2025 from 65,680 kEUR for the corresponding 2024 period, boosted by 16.3% growth in our Mat.